Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Profound Medical Corp. T.PRN

Alternate Symbol(s):  PROF

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

RE:RE:RE:More Share Bought by Profound Medical's management

Covid was holding them back via implementing the hospitals - not the reimbursement code. But what I'm talking about is their growth rate.  The permanent code is key to the growth rate in the...read more

RE:RE:More Share Bought by Profound Medical's management

In the Q2 conf call they indicated that the lack of a permanent reimbursement code was not holding them back in any significant way. That's a good thing considering that they said then they were...read more

RE:More Share Bought by Profound Medical's management

Should be imminent - very much tied to hospitals, reimbursement and a permanent reimbursement code.  rate and reply

More Share Bought by Profound Medical's management

It's important to note that following purchases has been made in the month of May 2022: Arun Menawat puchased 60516 shares, in addition to his previous puchases in Mar 2022 Brian Ellacott...read more

Quarterly ...

Install base of 24 - one shy of goal ?  Lost track of where they should be. World-wide install base is now 30. Some lingering side-effects on the logistics side. Pace of utilization will...read more

Profound to present ...

Profound Medical to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference      TORONTO, April 25, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp...read more

Leave it to Arun !!!

He just keeps accumulating shares. That's conviction. Another 60,000 shares.  rate and reply

RE:Quarterly Conference Call

I don't see how or why the re occuring revenue would not continue to grow moving forwrds.  rate and reply

RE:transcript - worth the read ...

"To date, we have been working with two MRI manufacturer partners, Siemens and Philips, to commercialize TULSA-PRO. Just this week, we were pleased to confirm TULSA-PRO's compatibility with...read more

transcript - worth the read ...

https://www.fool.com/earnings/call-transcripts/2022/03/04/profound-medical-corp-prof-q4-2021-earnings-call-t/  rate and reply

good recap mugs

$67mil in cash, seemed promising to me also other than the $1 mil in rev. 40 contracts or so signed, most getting reimbursed around $12500, they charge $8000 or so bumped up from $7K ish. interesting...read more

Quarterly Conference Call

Sounded promising but reoccurring revenue was only at $1M. Would like to think the worst is over but it's going to take time. Question is ... did we bottom out and are we heading the other...read more

Profound Medical’s TULSA-PRO® Now Compatible

TORONTO, March 01, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...read more

Q4 & FY2021 Financial Results March 3, Conf call to follow

Fourth Quarter and Full Year 2021 Results Conference Call Details: Date: Thursday, March 3, 2022 Time: 4:30 p.m. ET Live Call: 1-833-710-1825 (Canada and the United States) 1-929-517-0404...read more

quiet and cheap

havent heard much from the company lately, any one been in contact . have been nibbling a bit.   rate and reply

RE:Profound Medical to Participate in Virtual Conference

https://www.globenewswire.com/news-release/2022/02/08/2381373/33471/en/Profound-Medical-to-Participate-in-the-BTIG-MedTech-Digital-Health-Life-Science-Diagnostic-Tools-Virtual-Conference.html  rate and reply

Profound Medical to Participate in Virtual Conference

TORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...read more

Future looks good here

Nice to insiders buying, with options insiders hold over 10 % https://ca.finance.yahoo.com/news/bullish-profound-medical-corp-tse-124816167.html https://www.cantechletter.com/2021/12/profound...read more

First Patients Treated

TORONTO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...read more

05 Jan:Kenneth Knudson Joins PRN as Chief Commercial Officer

It sounds like they've added a heavy hitter with the right bio to take on the challenge of commercializing TULSO-PRO. It even moved the share price up the day of the annoucment. But that didn'...read more
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >